#USA #MarCom Awards #Florida Cancer Specialists #Fort Myers #Oncology Care

Florida Cancer Specialists Celebrates MarCom Gold Award

The Florida Cancer Specialists & Research Institute, LLC, proudly announces its recognition as a Gold Award Winner by the MarCom Awards for its remarkable 2025 Year in Review report. This marks the fourth consecutive year that FCS has been honored in this illustrious competition, which is regarded as one of the largest in the world recognizing excellence in marketing and communications.

The annual report received praise for its content and design, reflecting the commitment and creativity of the FCS team. Michelle Robey, Senior Vice President of Marketing and Communications at FCS, expressed gratitude for her team's collaborative efforts. She stated, "This recognition reflects the collaboration, creativity, and dedication of an exceptional team. I am grateful for each team member who so skillfully captured our strategic priorities and the meaningful impact of our work."

The 2025 Year in Review not only presents the achievements of the year but also documents the growth and innovation within the organization. It emphasizes the expanded access to innovative treatments and advances in precision medicine, which ultimately enhance the outcomes for cancer patients both in Florida and beyond.

FCS CEO Ryan Ciarrocchi articulated the organization's mission, saying, "At FCS, we are improving lives every day and helping shape the future of cancer care. This report highlights the dedication of our physicians, advanced practice providers, and team members, whose unwavering commitment to excellence continues to elevate the patient experience and positively impact the communities we serve."

Administered by the Association of Marketing & Communications Professionals, the MarCom Awards receive approximately 6,000 entries annually from around the globe, making the recognition even more significant for FCS. The organization's consistent success illustrates its leadership in the oncology field and its commitment to patient-centered care.

For over 40 years, the Florida Cancer Specialists & Research Institute has been at the forefront of innovation, revolutionizing oncology care through a robust clinical research program. FCS provides patients with access to numerous clinical trials, solidifying its status as a leader in research among private oncology practices in Florida and the nation. Their collaboration with the Sarah Cannon Research Institute (SCRI) enables FCS to provide cutting-edge therapies conveniently.

Through its clinical research efforts, FCS conducts over 180 active clinical trials each year, directly enhancing patient care and promoting advancement in oncology. Many of the cancer drugs approved by the FDA in the last decade were first accessible to patients at FCS through participation in clinical trials prior to their formal approval.

The organization prides itself on its highly trained and dedicated team of physicians who are devoted to creating personalized treatment plans that leverage the latest in precision oncology advancements to improve patient outcomes. This Gold MarCom Award underlines the esteemed reputation of Florida Cancer Specialists & Research Institute as a leader in both cancer care and clinical research, reaffirming its influential role in transforming the landscape of oncology treatment.

As FCS continues to push boundaries and foster innovation in cancer care, they remain committed to delivering excellence that benefits their patients and the broader community.